{"transactions":[{"id":781377,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":47769,"kind":"person","name":"Rowland Thomas Andrew","position":1,"cik":"0001507496","reported_name":"Rowland Thomas Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, HEAD - ESTABLISHED BRANDS"}}],"security":"Common Stock","published_at":"2026-05-13T20:16:49.000Z","date":"2026-05-12","kind":"sale","planned":false,"acquired":false,"shares":459,"price":79.21,"value":36357.39,"ownership":{"direct":true},"balance_after":38271,"source":{"system":"sec-edgar","filing":"0001507496-26-000012","document":"wk-form4_1778703407.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000150749626000012/wk-form4_1778703407.xml","form_type":"4"}},{"id":844627,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":47769,"kind":"person","name":"Rowland Thomas Andrew","position":1,"cik":"0001507496","reported_name":"Rowland Thomas Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, HEAD - ESTABLISHED BRANDS"}}],"security":"Common Stock","published_at":"2026-03-13T21:28:48.000Z","date":"2026-03-11","kind":"sale","planned":false,"acquired":false,"shares":4772,"price":74.91,"value":357470.52,"ownership":{"direct":true},"balance_after":38730,"source":{"system":"sec-edgar","filing":"0001507496-26-000009","document":"wk-form4_1773437312.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000150749626000009/wk-form4_1773437312.xml","form_type":"4"}},{"id":875180,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":47769,"kind":"person","name":"Rowland Thomas Andrew","position":1,"cik":"0001507496","reported_name":"Rowland Thomas Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, HEAD - ESTABLISHED BRANDS"}}],"security":"Common Stock","published_at":"2026-03-02T22:59:32.000Z","date":"2026-02-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":628,"price":73.9,"value":46409.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 2,171 shares of restricted stock, the grant of which was previously reported."}],"balance_after":43502,"source":{"system":"sec-edgar","filing":"0001507496-26-000007","document":"wk-form4_1772492369.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000150749626000007/wk-form4_1772492369.xml","form_type":"4"}},{"id":875179,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":47769,"kind":"person","name":"Rowland Thomas Andrew","position":1,"cik":"0001507496","reported_name":"Rowland Thomas Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, HEAD - ESTABLISHED BRANDS"}}],"security":"Common Stock","published_at":"2026-03-02T22:59:32.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":6021,"price":77.15,"value":464520.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 26, 2026."}],"balance_after":44130,"source":{"system":"sec-edgar","filing":"0001507496-26-000007","document":"wk-form4_1772492369.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000150749626000007/wk-form4_1772492369.xml","form_type":"4"}},{"id":902021,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":47769,"kind":"person","name":"Rowland Thomas Andrew","position":1,"cik":"0001507496","reported_name":"Rowland Thomas Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, HEAD - ESTABLISHED BRANDS"}}],"security":"Common Stock","published_at":"2026-02-17T21:08:52.000Z","date":"2026-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":485,"price":77.36,"value":37519.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 1,677 shares of restricted stock, the grant of which was previously reported."}],"balance_after":38109,"source":{"system":"sec-edgar","filing":"0001507496-26-000005","document":"wk-form4_1771362529.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000150749626000005/wk-form4_1771362529.xml","form_type":"4"}},{"id":902020,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":47769,"kind":"person","name":"Rowland Thomas Andrew","position":1,"cik":"0001507496","reported_name":"Rowland Thomas Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, HEAD - ESTABLISHED BRANDS"}}],"security":"Common Stock","published_at":"2026-02-17T21:08:52.000Z","date":"2026-02-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":566,"price":76.7,"value":43412.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 1,958 shares of restricted stock, the grant of which was previously reported."}],"balance_after":38594,"source":{"system":"sec-edgar","filing":"0001507496-26-000005","document":"wk-form4_1771362529.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000150749626000005/wk-form4_1771362529.xml","form_type":"4"}},{"id":905859,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":47769,"kind":"person","name":"Rowland Thomas Andrew","position":1,"cik":"0001507496","reported_name":"Rowland Thomas Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, HEAD - ESTABLISHED BRANDS"}}],"security":"Common Stock","published_at":"2026-02-13T21:07:51.000Z","date":"2026-02-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":1762,"price":76.25,"value":134352.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 5,788 performance stock units, the grant of which was previously reported."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 128 shares of ANI Pharmaceuticals, Inc. Common Stock that were acquired under the ANI Pharmaceuticals, Inc. Employee Stock Purchase Plan in transactions that were exempt under Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":39160,"source":{"system":"sec-edgar","filing":"0001507496-26-000003","document":"wk-form4_1771016868.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000150749626000003/wk-form4_1771016868.xml","form_type":"4"}},{"id":1066883,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":47769,"kind":"person","name":"Rowland Thomas Andrew","position":1,"cik":"0001507496","reported_name":"Rowland Thomas Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, HEAD - ESTABLISHED BRANDS"}}],"security":"Common Stock","published_at":"2025-08-14T21:53:08.000Z","date":"2025-08-12","kind":"sale","planned":false,"acquired":false,"shares":4975,"price":85.71,"value":426407.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold in multiple trades at prices ranging from $85.52 to $86.22. The price reported above reflects the weighted average sales price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 304 shares of ANI Pharmaceuticals, Inc. Common Stock that were acquired under the ANI Pharmaceuticals, Inc. Employee Stock Purchase Plan in transactions that were exempt under Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":40794,"source":{"system":"sec-edgar","filing":"0001507496-25-000007","document":"wk-form4_1755208382.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000150749625000007/wk-form4_1755208382.xml","form_type":"4"}},{"id":1231389,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":47769,"kind":"person","name":"Rowland Thomas Andrew","position":1,"cik":"0001507496","reported_name":"Rowland Thomas Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, HEAD - ESTABLISHED BRANDS"}}],"security":"Common Stock","published_at":"2025-03-04T22:15:04.000Z","date":"2025-02-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":627,"price":61.89,"value":38805.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 2,171 shares of restricted stock, the grant of which was previously reported."}],"balance_after":45465,"source":{"system":"sec-edgar","filing":"0001507496-25-000004","document":"wk-form4_1741126494.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000150749625000004/wk-form4_1741126494.xml","form_type":"4"}},{"id":1264831,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":47769,"kind":"person","name":"Rowland Thomas Andrew","position":1,"cik":"0001507496","reported_name":"Rowland Thomas Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, HEAD - ESTABLISHED BRANDS"}}],"security":"Common Stock","published_at":"2025-02-19T01:19:08.000Z","date":"2025-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":582,"price":58.92,"value":34291.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 1,677 shares of restricted stock, the grant of which was previously reported."}],"balance_after":46092,"source":{"system":"sec-edgar","filing":"0001507496-25-000002","document":"wk-form4_1739927941.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000150749625000002/wk-form4_1739927941.xml","form_type":"4"}},{"id":1264830,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":47769,"kind":"person","name":"Rowland Thomas Andrew","position":1,"cik":"0001507496","reported_name":"Rowland Thomas Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, HEAD - ESTABLISHED BRANDS"}}],"security":"Common Stock","published_at":"2025-02-19T01:19:08.000Z","date":"2025-02-12","kind":"grant","planned":false,"acquired":true,"shares":5222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting."}],"balance_after":46674,"source":{"system":"sec-edgar","filing":"0001507496-25-000002","document":"wk-form4_1739927941.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000150749625000002/wk-form4_1739927941.xml","form_type":"4"}},{"id":1264829,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":47769,"kind":"person","name":"Rowland Thomas Andrew","position":1,"cik":"0001507496","reported_name":"Rowland Thomas Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, HEAD - ESTABLISHED BRANDS"}}],"security":"Common Stock","published_at":"2025-02-19T01:19:08.000Z","date":"2025-02-12","kind":"grant","planned":false,"acquired":true,"shares":7834,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 12, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 449 shares of ANI Pharmaceuticals, Inc. Common Stock that were acquired under the ANI Pharmaceuticals, Inc. Employee Stock Purchase Plan in transactions that were exempt under Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":41452,"source":{"system":"sec-edgar","filing":"0001507496-25-000002","document":"wk-form4_1739927941.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000150749625000002/wk-form4_1739927941.xml","form_type":"4"}},{"id":1362368,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":47769,"kind":"person","name":"Rowland Thomas Andrew","position":1,"cik":"0001507496","reported_name":"Rowland Thomas Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, HEAD - ESTABLISHED BRANDS"}}],"security":"Common Stock","published_at":"2024-11-18T21:05:16.000Z","date":"2024-11-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":867,"price":56.58,"value":49054.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,000 shares of restricted stock, the grant of which was previously reported."}],"balance_after":33169,"source":{"system":"sec-edgar","filing":"0001507496-24-000006","document":"wk-form4_1731963909.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000150749624000006/wk-form4_1731963909.xml","form_type":"4"}}]}